Showing results (121-130 of 160) with videos related to
Sort By:
Pageof 16
Endocrine|May 17, 2023
Predicting the HbA1c level following glucose-lowering interventions in individuals with HbA1c-defined prediabetes: a post-hoc analysis from the randomized controlled PRE-D trialLea Bruhn, Dorte Vistisen, Hanan Amadid, et al.Diabetes, Obesity & Metabolism|July 4, 2020
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trialOfri Mosenzon, Stephen C Bain, Hiddo J L Heerspink, et al.Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.Diabetes Care|January 19, 2023
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover TrialViktor Rotbain Curovic, Niels Jongs, Marjolein Y A M Kroonen, et al.BMJ Open|June 6, 2023
Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)Marie Møller, Rikke Borg, Iain Bressendorff, et al.The Lancet. Diabetes & Endocrinology|January 18, 2016
Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trialHiddo J L Heerspink, Frederik Persson, Barry M Brenner, et al.Diabetes, Obesity & Metabolism|October 29, 2024
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY studyVictor Wasehuus, Viktor Rotbain Curovic, Nete Tofte, et al.BMJ Open|March 4, 2016
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trialMorten Lindhardt, Frederik Persson, Gemma Currie, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2016
Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 studyMorten Lindhardt, Frederik Persson, Petra Zürbig, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 16, 2012
Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)Hans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.Pageof 16